PEGFILGRASTIM-JMDB

PEGFILGRASTIM-JMDB was reported 452 times

PEGFILGRASTIM-JMDB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEUROENDOCRINE TUMOUR OF THE RECTUM 1 0.0312
1 PRODUCT ORIGIN UNKNOWN 1 0.0233
2 PLASMA CELL MYELOMA IN REMISSION 1 0.0192
3 PLASMA CELLS INCREASED 1 0.0137
4 BONE MARROW MYELOGRAM ABNORMAL 2 0.0115
5 SMALL INTESTINE ADENOCARCINOMA 2 0.0112
6 BENIGN NEOPLASM OF SPINAL CORD 1 0.0111
7 GLUCOCORTICOID DEFICIENCY 4 0.0095
8 VIRAL SKIN INFECTION 1 0.0081
9 IMMUNE-MEDIATED HYPERTHYROIDISM 2 0.0079
10 GASTRIC CANCER RECURRENT 1 0.0077
11 COLON CANCER STAGE I 1 0.0057
12 CORONARY ANGIOPLASTY 2 0.0044
13 DEVICE USE CONFUSION 2 0.0038
14 INTESTINAL SEPSIS 1 0.0038
15 IMMUNE-MEDIATED HYPOTHYROIDISM 3 0.0027
16 MYELOID LEUKAEMIA 1 0.0020
17 TONGUE PARALYSIS 1 0.0014
18 NOROVIRUS INFECTION 2 0.0014
19 HENOCH-SCHONLEIN PURPURA 3 0.0014
20 CHOLANGIOCARCINOMA 2 0.0013
21 ENTEROCOCCAL SEPSIS 1 0.0012
22 INJECTION RELATED REACTION 2 0.0012
23 SEPTIC EMBOLUS 1 0.0012
24 WRONG SCHEDULE 1 0.0010
25 DEVICE SAFETY FEATURE ISSUE 1 0.0010
26 EMERGENCY CARE 3 0.0010
27 HYDROCELE 1 0.0009
28 GALLBLADDER ENLARGEMENT 1 0.0009
29 SARCOMA 1 0.0009
30 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
31 PO2 DECREASED 1 0.0009
32 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
33 BILIARY OBSTRUCTION 1 0.0008
34 INVASIVE DUCTAL BREAST CARCINOMA 2 0.0007
35 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
36 SPLENIC RUPTURE 1 0.0006
37 DEVICE MECHANICAL ISSUE 8 0.0006
38 SPINAL CORD INJURY 1 0.0006
39 SPLENIC INFARCTION 1 0.0006
40 LIPASE INCREASED 4 0.0005
41 DEVICE DEFECTIVE 9 0.0005
42 NEEDLE ISSUE 15 0.0005
43 ATROPHY 1 0.0005
44 APLASIA 1 0.0005
45 OESOPHAGEAL CANDIDIASIS 2 0.0005
46 ANAPHYLACTOID REACTION 2 0.0005
47 NEUTROPENIC COLITIS 1 0.0005
48 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
49 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
50 URINARY TRACT OBSTRUCTION 1 0.0004
51 PANNICULITIS 1 0.0004
52 VENOOCCLUSIVE LIVER DISEASE 2 0.0004
53 GASTROINTESTINAL TUBE INSERTION 1 0.0004
54 ERYSIPELAS 2 0.0004
55 HAEMORRHAGE URINARY TRACT 1 0.0004
56 DEVICE LEAKAGE 17 0.0004
57 WHITE BLOOD CELL DISORDER 1 0.0004
58 NEUTROPHIL COUNT ABNORMAL 1 0.0004
59 SYRINGE ISSUE 6 0.0003
60 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
61 ATYPICAL PNEUMONIA 1 0.0003
62 FEBRILE NEUTROPENIA 22 0.0003
63 BONE MARROW DISORDER 1 0.0003
64 PRODUCT DISTRIBUTION ISSUE 3 0.0003
65 B-CELL LYMPHOMA 1 0.0003
66 OESOPHAGITIS 3 0.0003
67 FOOD INTOLERANCE 1 0.0003
68 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
69 SPINAL CORD COMPRESSION 1 0.0003
70 SKIN PAPILLOMA 1 0.0002
71 ONYCHOMADESIS 1 0.0002
72 CHAPPED LIPS 1 0.0002
73 RHINITIS ALLERGIC 1 0.0002
74 FACIAL PAIN 2 0.0002
75 SUSPECTED OFF LABEL USE 1 0.0002
76 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
77 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
78 SKIN ABRASION 1 0.0002
79 PRODUCT PACKAGING ISSUE 2 0.0002
80 ENTEROCOCCAL INFECTION 1 0.0002
81 RASH VESICULAR 1 0.0002
82 STAPHYLOCOCCAL SEPSIS 1 0.0002
83 HOSPICE CARE 2 0.0002
84 MUCOUS STOOLS 1 0.0002
85 IMMUNODEFICIENCY 3 0.0002
86 FLUID INTAKE REDUCED 1 0.0002
87 KLEBSIELLA INFECTION 1 0.0002
88 DEVICE BREAKAGE 8 0.0002
89 DEVICE RELATED INFECTION 3 0.0002
90 TRISMUS 1 0.0002
91 EATING DISORDER 4 0.0002
92 BONE PAIN 11 0.0002
93 ANAL FISTULA 1 0.0002
94 BREAST CANCER METASTATIC 2 0.0002
95 INJECTION SITE DISCHARGE 1 0.0002
96 NECROSIS 1 0.0002
97 NEOPLASM 2 0.0002
98 PRODUCT LABEL CONFUSION 1 0.0002
99 PLATELET COUNT ABNORMAL 1 0.0002
100 CYTOPENIA 2 0.0002
101 NEUTROPENIA 22 0.0002
102 GENERALISED OEDEMA 2 0.0002
103 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
104 PRODUCT QUALITY ISSUE 21 0.0002
105 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
106 APPETITE DISORDER 1 0.0002
107 FULL BLOOD COUNT DECREASED 3 0.0001
108 CORONARY ARTERY OCCLUSION 2 0.0001
109 FEAR OF INJECTION 1 0.0001
110 GRAFT VERSUS HOST DISEASE 1 0.0001
111 COLON CANCER 2 0.0001
112 DEVICE FAILURE 2 0.0001
113 INSURANCE ISSUE 2 0.0001
114 HYPOALBUMINAEMIA 1 0.0001
115 HAEMORRHAGIC STROKE 1 0.0001
116 NEUTROPHIL COUNT DECREASED 5 0.0001
117 DEVICE ISSUE 11 0.0001
118 ABNORMAL FAECES 1 0.0001
119 HYPERAESTHESIA 1 0.0001
120 SECOND PRIMARY MALIGNANCY 1 0.0001
121 FACIAL PARALYSIS 1 0.0001
122 HOSPITALISATION 18 0.0001
123 RASH GENERALISED 3 0.0001
124 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
125 PRODUCT COMMUNICATION ISSUE 1 0.0001
126 MYOSITIS 1 0.0001
127 LIP DRY 1 0.0001
128 AGRANULOCYTOSIS 2 0.0001
129 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
130 VITAMIN D DEFICIENCY 1 0.0001
131 BRAIN INJURY 1 0.0001
132 CYTOKINE RELEASE SYNDROME 2 0.0001
133 TOXIC SKIN ERUPTION 1 0.0001
134 BODY TEMPERATURE INCREASED 2 0.0001
135 TENDERNESS 1 0.0001
136 TRANSFUSION 1 0.0001
137 FULL BLOOD COUNT ABNORMAL 1 0.0001
138 PRODUCT PRESCRIBING ISSUE 2 0.0001
139 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
140 PRODUCT STORAGE ERROR 8 0.0001
141 FISTULA 1 0.0001
142 VASCULITIS 1 0.0001
143 DEVICE MALFUNCTION 6 0.0001
144 DISEASE PROGRESSION 10 0.0001
145 BACTERAEMIA 1 0.0001
146 ACCIDENT 1 0.0001
147 DEATH 70 0.0001
148 SEPSIS 9 0.0001
149 CELLULITIS 4 0.0001
150 DEVICE DEPLOYMENT ISSUE 1 0.0001
151 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
152 THERAPY CESSATION 4 0.0001
153 MUCOSAL INFLAMMATION 2 0.0001
154 IMMUNE SYSTEM DISORDER 1 0.0001
155 ADVERSE REACTION 1 0.0001
156 NEOPLASM MALIGNANT 5 0.0001
157 TACHYPNOEA 1 0.0001
158 HAEMOPTYSIS 2 0.0001
159 MASS 1 0.0001
160 BLOOD TEST ABNORMAL 1 0.0001
161 DEVICE OCCLUSION 1 0.0001
162 SINUS TACHYCARDIA 1 0.0001
163 MYELODYSPLASTIC SYNDROME 1 0.0001
164 SEPTIC SHOCK 3 0.0001
165 DYSSTASIA 2 0.0001
166 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
167 ILLNESS 7 0.0001
168 PULMONARY MASS 1 0.0001
169 GASTROINTESTINAL DISORDER 6 0.0001
170 PLEURAL EFFUSION 4 0.0001
171 THYROID DISORDER 1 0.0001
172 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
173 PNEUMOTHORAX 1 0.0001
174 ABSCESS 1 0.0001
175 MUSCLE TIGHTNESS 1 0.0001
176 AGGRESSION 3 0.0001
177 CANDIDA INFECTION 1 0.0001
178 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
179 DELIRIUM 2 0.0001
180 HYPOXIA 2 0.0001
181 LEUKOCYTOSIS 1 0.0001
182 ANAPHYLACTIC REACTION 3 0.0001
183 PHOTOPHOBIA 1 0.0001
184 MYALGIA 9 0.0001
185 KIDNEY INFECTION 1 0.0001
186 DISABILITY 1 0.0001
187 BLOOD PRESSURE ABNORMAL 1 0.0001
188 PRESCRIBED UNDERDOSE 1 0.0001
189 FEEDING DISORDER 1 0.0000
190 PYREXIA 17 0.0000
191 INJURY ASSOCIATED WITH DEVICE 1 0.0000
192 CARDIO-RESPIRATORY ARREST 2 0.0000
193 MOUTH ULCERATION 1 0.0000
194 PLATELET COUNT DECREASED 5 0.0000
195 DEEP VEIN THROMBOSIS 3 0.0000
196 DEHYDRATION 6 0.0000
197 ORAL PAIN 1 0.0000
198 RASH PAPULAR 1 0.0000
199 PRODUCT DOSE OMISSION ISSUE 13 0.0000
200 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
201 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
202 CHILLS 5 0.0000
203 DYSPHAGIA 4 0.0000
204 NEUROPATHY PERIPHERAL 4 0.0000
205 PRODUCTIVE COUGH 2 0.0000
206 RESPIRATORY FAILURE 3 0.0000
207 PNEUMONIA ASPIRATION 1 0.0000
208 LEUKOPENIA 2 0.0000
209 ABDOMINAL PAIN LOWER 1 0.0000
210 FLUID RETENTION 2 0.0000
211 PERIPHERAL SWELLING 6 0.0000
212 ANAPHYLACTIC SHOCK 1 0.0000
213 UNRESPONSIVE TO STIMULI 1 0.0000
214 RESPIRATORY TRACT INFECTION 1 0.0000
215 VOMITING 18 0.0000
216 DEAFNESS 1 0.0000
217 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
218 GASTRITIS 1 0.0000
219 FEAR 1 0.0000
220 BLOOD BILIRUBIN INCREASED 1 0.0000
221 LIMB INJURY 1 0.0000
222 FEELING COLD 1 0.0000
223 PANCYTOPENIA 2 0.0000
224 WOUND 1 0.0000
225 INTENTIONAL DOSE OMISSION 1 0.0000
226 RED BLOOD CELL COUNT DECREASED 1 0.0000
227 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
228 SEIZURE 4 0.0000
229 PALPITATIONS 4 0.0000
230 PNEUMONIA 11 0.0000
231 LABORATORY TEST ABNORMAL 1 0.0000
232 URINARY INCONTINENCE 1 0.0000
233 ADVERSE DRUG REACTION 3 0.0000
234 OFF LABEL USE 29 0.0000
235 LACRIMATION INCREASED 1 0.0000
236 NASOPHARYNGITIS 6 0.0000
237 NAUSEA 25 0.0000
238 HYPOTHYROIDISM 1 0.0000
239 CONFUSIONAL STATE 5 0.0000
240 PRODUCT DOSE OMISSION 2 0.0000
241 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
242 DECREASED APPETITE 7 0.0000
243 VIRAL INFECTION 1 0.0000
244 URINARY RETENTION 1 0.0000
245 GAIT INABILITY 1 0.0000
246 FLUSHING 3 0.0000
247 HAEMOGLOBIN DECREASED 3 0.0000
248 HAEMATURIA 1 0.0000
249 ABDOMINAL PAIN UPPER 6 0.0000
250 GASTRIC DISORDER 1 0.0000
251 NEOPLASM PROGRESSION 1 0.0000
252 LYMPHADENOPATHY 1 0.0000
253 THERAPY INTERRUPTED 2 0.0000
254 DIARRHOEA 18 0.0000
255 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
256 MYELOSUPPRESSION 1 0.0000
257 INFECTION 4 0.0000
258 DYSARTHRIA 1 0.0000
259 MUSCULAR WEAKNESS 3 0.0000
260 COLITIS 1 0.0000
261 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
262 DISORIENTATION 1 0.0000
263 RASH 11 0.0000
264 EXTRA DOSE ADMINISTERED 1 0.0000
265 CARDIAC ARREST 2 0.0000
266 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
267 RHABDOMYOLYSIS 1 0.0000
268 POLLAKIURIA 1 0.0000
269 ASTHENIA 9 0.0000
270 ABDOMINAL DISCOMFORT 4 0.0000
271 DEVICE DISLOCATION 1 0.0000
272 LIVER DISORDER 1 0.0000
273 TACHYCARDIA 2 0.0000
274 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
275 NEPHROLITHIASIS 1 0.0000
276 ADVERSE EVENT 2 0.0000
277 HYPOKALAEMIA 1 0.0000
278 HYPERSENSITIVITY 4 0.0000
279 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
280 OCULAR HYPERAEMIA 1 0.0000
281 MIGRAINE 2 0.0000
282 RASH ERYTHEMATOUS 1 0.0000
283 BLOOD GLUCOSE DECREASED 1 0.0000
284 PAIN IN EXTREMITY 6 0.0000
285 DYSPEPSIA 2 0.0000
286 INFLAMMATION 1 0.0000
287 DRUG INEFFECTIVE 25 0.0000
288 PANCREATITIS 1 0.0000
289 CONSTIPATION 4 0.0000
290 INFLUENZA 2 0.0000
291 NECK PAIN 1 0.0000
292 THROMBOCYTOPENIA 2 0.0000
293 HYPONATRAEMIA 1 0.0000
294 INCORRECT DOSE ADMINISTERED 4 0.0000
295 LETHARGY 1 0.0000
296 MYOCARDIAL INFARCTION 3 0.0000
297 ABDOMINAL PAIN 4 0.0000
298 DYSPHONIA 1 0.0000
299 SURGERY 1 0.0000
300 FATIGUE 13 0.0000
301 FEELING HOT 1 0.0000
302 ANAEMIA 3 0.0000
303 RHINORRHOEA 1 0.0000
304 ALOPECIA 3 0.0000
305 DEVICE DIFFICULT TO USE 1 0.0000
306 HEPATIC ENZYME INCREASED 1 0.0000
307 PAIN 9 0.0000
308 ERYTHEMA 3 0.0000
309 HOT FLUSH 1 0.0000
310 UNEVALUABLE EVENT 1 0.0000
311 ACNE 1 0.0000
312 DEPRESSION 3 0.0000
313 DIABETES MELLITUS 1 0.0000
314 BLOOD PRESSURE INCREASED 2 0.0000
315 BACK PAIN 3 0.0000
316 INJECTION SITE BRUISING 1 0.0000
317 PROSTATE CANCER 1 0.0000
318 THROMBOSIS 1 0.0000
319 RENAL IMPAIRMENT 1 0.0000
320 URINARY TRACT INFECTION 2 0.0000
321 INTENTIONAL PRODUCT MISUSE 1 0.0000
322 COVID-19 2 0.0000
323 NO ADVERSE EVENT 2 0.0000
324 MUSCLE SPASMS 2 0.0000
325 WEIGHT DECREASED 3 0.0000
326 BREAST CANCER 1 0.0000
327 COUGH 3 0.0000
328 CARDIAC DISORDER 1 0.0000
329 SWELLING 1 0.0000
330 PRODUCT USE ISSUE 2 0.0000
331 DYSPNOEA 6 0.0000
332 CONTUSION 1 0.0000
333 DRUG INTOLERANCE 1 0.0000
334 SYNCOPE 1 0.0000
335 CHEST DISCOMFORT 1 0.0000
336 SINUSITIS 1 0.0000
337 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
338 ABDOMINAL DISTENSION 1 0.0000
339 HAEMORRHAGE 1 0.0000
340 HYPERTENSION 2 0.0000
341 MALAISE 4 0.0000
342 OEDEMA PERIPHERAL 1 0.0000
343 VISUAL IMPAIRMENT 1 0.0000
344 INJECTION SITE ERYTHEMA 1 0.0000
345 HEADACHE 5 0.0000
346 RENAL FAILURE 1 0.0000
347 MEMORY IMPAIRMENT 1 0.0000
348 ACUTE KIDNEY INJURY 1 0.0000
349 DRUG INTERACTION 1 0.0000
350 TREMOR 1 0.0000
351 URTICARIA 1 0.0000
352 CEREBROVASCULAR ACCIDENT 1 0.0000
353 BLOOD GLUCOSE INCREASED 1 0.0000
354 HYPOTENSION 1 0.0000
355 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
356 ARTHRALGIA 2 0.0000
357 FEELING ABNORMAL 1 0.0000
358 DIZZINESS 2 0.0000
359 ANXIETY 1 0.0000
360 CONDITION AGGRAVATED 1 0.0000
361 FALL 1 0.0000